Effects of the Selective Serotonin Reuptake Inhibitor Fluoxetine on Counterregulatory Responses to Hypoglycemia in Individuals With Type 1 Diabetes

OBJECTIVE—Previous work has demonstrated that chronic administration of the serotonin reuptake inhibitor (SSRI) fluoxetine augments counterregulatory responses to hypoglycemia in healthy humans. However, virtually no information exists regarding the effects of fluoxetine on integrated physiological...

Descripción completa

Detalles Bibliográficos
Autores principales: Briscoe, Vanessa J., Ertl, Andrew C., Tate, Donna B., Davis, Stephen N.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2008
Materias:
Pathophysiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2584138/
https://www.ncbi.nlm.nih.gov/pubmed/18835927
http://dx.doi.org/10.2337/db08-1000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2584138/
https://www.ncbi.nlm.nih.gov/pubmed/18835927
http://dx.doi.org/10.2337/db08-1000

Ejemplares similares